nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—coronary artery disease	0.157	1	CbGaD
Phenylbutazone—SLC22A11—Pravastatin—coronary artery disease	0.0557	0.0809	CbGbCtD
Phenylbutazone—SLC22A11—Furosemide—coronary artery disease	0.0473	0.0687	CbGbCtD
Phenylbutazone—SLC22A8—Enalapril—coronary artery disease	0.0458	0.0665	CbGbCtD
Phenylbutazone—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0326	0.0474	CbGbCtD
Phenylbutazone—SLC22A8—Pravastatin—coronary artery disease	0.0324	0.047	CbGbCtD
Phenylbutazone—SLC22A6—Enalapril—coronary artery disease	0.0319	0.0463	CbGbCtD
Phenylbutazone—PTGS1—Acetylsalicylic acid—coronary artery disease	0.0276	0.04	CbGbCtD
Phenylbutazone—SLC22A8—Furosemide—coronary artery disease	0.0275	0.04	CbGbCtD
Phenylbutazone—CYP2C9—Fenofibrate—coronary artery disease	0.0255	0.037	CbGbCtD
Phenylbutazone—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0242	0.0351	CbGbCtD
Phenylbutazone—SLC22A6—Captopril—coronary artery disease	0.0239	0.0347	CbGbCtD
Phenylbutazone—SLC22A6—Pravastatin—coronary artery disease	0.0226	0.0328	CbGbCtD
Phenylbutazone—CYP2C9—Gemfibrozil—coronary artery disease	0.0204	0.0296	CbGbCtD
Phenylbutazone—SLC22A6—Furosemide—coronary artery disease	0.0192	0.0279	CbGbCtD
Phenylbutazone—SLC22A6—Losartan—coronary artery disease	0.0188	0.0273	CbGbCtD
Phenylbutazone—CYP2C9—Clopidogrel—coronary artery disease	0.0177	0.0256	CbGbCtD
Phenylbutazone—CYP3A4—Ticagrelor—coronary artery disease	0.0166	0.0241	CbGbCtD
Phenylbutazone—CYP2C9—Pitavastatin—coronary artery disease	0.0154	0.0224	CbGbCtD
Phenylbutazone—CYP2C9—Valsartan—coronary artery disease	0.015	0.0218	CbGbCtD
Phenylbutazone—CYP3A4—Fenofibrate—coronary artery disease	0.0148	0.0215	CbGbCtD
Phenylbutazone—CYP3A4—Gemfibrozil—coronary artery disease	0.0118	0.0172	CbGbCtD
Phenylbutazone—CYP2C9—Rosuvastatin—coronary artery disease	0.0114	0.0165	CbGbCtD
Phenylbutazone—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0111	0.0161	CbGbCtD
Phenylbutazone—CYP2C9—Simvastatin—coronary artery disease	0.0106	0.0154	CbGbCtD
Phenylbutazone—CYP2C9—Pravastatin—coronary artery disease	0.0104	0.015	CbGbCtD
Phenylbutazone—CYP2C9—Lovastatin—coronary artery disease	0.0104	0.015	CbGbCtD
Phenylbutazone—CYP3A4—Clopidogrel—coronary artery disease	0.0103	0.0149	CbGbCtD
Phenylbutazone—CYP3A4—Eplerenone—coronary artery disease	0.00955	0.0139	CbGbCtD
Phenylbutazone—CYP2C9—Atorvastatin—coronary artery disease	0.00943	0.0137	CbGbCtD
Phenylbutazone—CYP2C9—cardial valve—coronary artery disease	0.00929	0.229	CbGeAlD
Phenylbutazone—CYP2C9—Losartan—coronary artery disease	0.00862	0.0125	CbGbCtD
Phenylbutazone—CYP3A4—Enalapril—coronary artery disease	0.00851	0.0124	CbGbCtD
Phenylbutazone—PTGIS—artery—coronary artery disease	0.00679	0.167	CbGeAlD
Phenylbutazone—CYP3A4—Rosuvastatin—coronary artery disease	0.00662	0.00961	CbGbCtD
Phenylbutazone—CYP3A4—Ezetimibe—coronary artery disease	0.00662	0.00961	CbGbCtD
Phenylbutazone—CYP3A4—Simvastatin—coronary artery disease	0.00615	0.00893	CbGbCtD
Phenylbutazone—CYP3A4—Pravastatin—coronary artery disease	0.00602	0.00874	CbGbCtD
Phenylbutazone—CYP3A4—Lovastatin—coronary artery disease	0.00602	0.00874	CbGbCtD
Phenylbutazone—PTGIS—endothelium—coronary artery disease	0.00573	0.141	CbGeAlD
Phenylbutazone—CYP3A4—Atorvastatin—coronary artery disease	0.00548	0.00796	CbGbCtD
Phenylbutazone—CYP3A4—Losartan—coronary artery disease	0.00501	0.00728	CbGbCtD
Phenylbutazone—PTGIS—myocardium—coronary artery disease	0.00358	0.0882	CbGeAlD
Phenylbutazone—PTGIS—heart—coronary artery disease	0.0025	0.0615	CbGeAlD
Phenylbutazone—PTGIS—cardiovascular system—coronary artery disease	0.00236	0.0581	CbGeAlD
Phenylbutazone—Phenindione—VKORC1—coronary artery disease	0.00189	0.381	CrCbGaD
Phenylbutazone—PTGS1—artery—coronary artery disease	0.00127	0.0313	CbGeAlD
Phenylbutazone—PTGS2—artery—coronary artery disease	0.00122	0.0299	CbGeAlD
Phenylbutazone—PTGS1—endothelium—coronary artery disease	0.00107	0.0264	CbGeAlD
Phenylbutazone—Phenprocoumon—VKORC1—coronary artery disease	0.00104	0.209	CrCbGaD
Phenylbutazone—PTGS2—endothelium—coronary artery disease	0.00103	0.0253	CbGeAlD
Phenylbutazone—PTGS1—myocardium—coronary artery disease	0.000671	0.0165	CbGeAlD
Phenylbutazone—SLC22A8—blood—coronary artery disease	0.000589	0.0145	CbGeAlD
Phenylbutazone—CYP2C9—heart—coronary artery disease	0.000513	0.0126	CbGeAlD
Phenylbutazone—CYP2C9—cardiovascular system—coronary artery disease	0.000484	0.0119	CbGeAlD
Phenylbutazone—PTGS1—heart—coronary artery disease	0.000468	0.0115	CbGeAlD
Phenylbutazone—PTGS2—heart—coronary artery disease	0.000448	0.011	CbGeAlD
Phenylbutazone—PTGS1—cardiovascular system—coronary artery disease	0.000442	0.0109	CbGeAlD
Phenylbutazone—PTGS2—cardiovascular system—coronary artery disease	0.000423	0.0104	CbGeAlD
Phenylbutazone—PTGS1—cardiac atrium—coronary artery disease	0.000401	0.00986	CbGeAlD
Phenylbutazone—CYP2C9—blood—coronary artery disease	0.000383	0.00942	CbGeAlD
Phenylbutazone—PTGS1—blood—coronary artery disease	0.00035	0.0086	CbGeAlD
Phenylbutazone—PTGS2—blood—coronary artery disease	0.000334	0.00822	CbGeAlD
Phenylbutazone—CYP3A4—blood—coronary artery disease	0.000292	0.00719	CbGeAlD
Phenylbutazone—Dextropropoxyphene—OPRD1—coronary artery disease	0.000259	0.0522	CrCbGaD
Phenylbutazone—Fentanyl—OPRD1—coronary artery disease	0.000256	0.0516	CrCbGaD
Phenylbutazone—Phenoxybenzamine—SLC22A3—coronary artery disease	0.00022	0.0444	CrCbGaD
Phenylbutazone—Fosphenytoin—CYP2C19—coronary artery disease	0.00021	0.0423	CrCbGaD
Phenylbutazone—Methadone—OPRD1—coronary artery disease	0.000176	0.0354	CrCbGaD
Phenylbutazone—Oxaprozin—PTGS2—coronary artery disease	0.000126	0.0254	CrCbGaD
Phenylbutazone—Fosphenytoin—ALB—coronary artery disease	0.000117	0.0235	CrCbGaD
Phenylbutazone—Modafinil—CYP2C19—coronary artery disease	0.000105	0.0211	CrCbGaD
Phenylbutazone—Clobazam—CYP2C19—coronary artery disease	0.000102	0.0205	CrCbGaD
Phenylbutazone—Phenoxybenzamine—ADRB2—coronary artery disease	0.000101	0.0203	CrCbGaD
Phenylbutazone—Phenytoin—CYP2C19—coronary artery disease	9.3e-05	0.0187	CrCbGaD
Phenylbutazone—Phenprocoumon—ALB—coronary artery disease	8e-05	0.0161	CrCbGaD
Phenylbutazone—Diphenhydramine—CYP2C19—coronary artery disease	7.28e-05	0.0146	CrCbGaD
Phenylbutazone—Methadone—CYP2C19—coronary artery disease	7.03e-05	0.0141	CrCbGaD
Phenylbutazone—Phenytoin—ALB—coronary artery disease	5.16e-05	0.0104	CrCbGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	9.17e-06	8.42e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TXNRD1—coronary artery disease	9.16e-06	8.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP11B2—coronary artery disease	9.16e-06	8.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GGT1—coronary artery disease	9.16e-06	8.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GOT1—coronary artery disease	9.16e-06	8.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	9.14e-06	8.39e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC22A3—coronary artery disease	9.03e-06	8.28e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—coronary artery disease	9.02e-06	8.28e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HADH—coronary artery disease	8.9e-06	8.16e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ARNTL—coronary artery disease	8.9e-06	8.16e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MDH2—coronary artery disease	8.86e-06	8.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPAT—coronary artery disease	8.86e-06	8.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—UGCG—coronary artery disease	8.86e-06	8.13e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLCD1—coronary artery disease	8.86e-06	8.13e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	8.76e-06	8.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PSMB5—coronary artery disease	8.7e-06	7.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PSMA6—coronary artery disease	8.7e-06	7.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.68e-06	7.97e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GOT1—coronary artery disease	8.68e-06	7.97e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	8.54e-06	7.84e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—coronary artery disease	8.53e-06	7.83e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PGM1—coronary artery disease	8.53e-06	7.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CTGF—coronary artery disease	8.5e-06	7.8e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA2—coronary artery disease	8.43e-06	7.74e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX2—coronary artery disease	8.43e-06	7.74e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	8.43e-06	7.74e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMGCR—coronary artery disease	8.42e-06	7.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GOT2—coronary artery disease	8.42e-06	7.73e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HK1—coronary artery disease	8.33e-06	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SULT1A1—coronary artery disease	8.33e-06	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCG5—coronary artery disease	8.33e-06	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX4—coronary artery disease	8.33e-06	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	8.32e-06	7.64e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—coronary artery disease	8.32e-06	7.63e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PYGB—coronary artery disease	8.23e-06	7.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CKB—coronary artery disease	8.23e-06	7.56e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HADHA—coronary artery disease	8.23e-06	7.55e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTP1—coronary artery disease	8.23e-06	7.55e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARGC1A—coronary artery disease	8.15e-06	7.48e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTA1—coronary artery disease	8.14e-06	7.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—HMOX1—coronary artery disease	8.11e-06	7.44e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPA—coronary artery disease	8.05e-06	7.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCE—coronary artery disease	8.01e-06	7.35e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAT—coronary artery disease	8e-06	7.34e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFBR2—coronary artery disease	7.8e-06	7.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KITLG—coronary artery disease	7.8e-06	7.15e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLCB3—coronary artery disease	7.79e-06	7.15e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOB—coronary artery disease	7.77e-06	7.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PLCB1—coronary artery disease	7.74e-06	7.11e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLIN1—coronary artery disease	7.74e-06	7.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DLAT—coronary artery disease	7.74e-06	7.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—COX5B—coronary artery disease	7.74e-06	7.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM2—coronary artery disease	7.74e-06	7.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PFKFB3—coronary artery disease	7.74e-06	7.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA5—coronary artery disease	7.71e-06	7.08e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT5A—coronary artery disease	7.62e-06	6.99e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—P4HB—coronary artery disease	7.56e-06	6.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTM1—coronary artery disease	7.56e-06	6.94e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCA1—coronary artery disease	7.51e-06	6.89e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.49e-06	6.88e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	7.43e-06	6.81e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—LPL—coronary artery disease	7.42e-06	6.81e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOB—coronary artery disease	7.37e-06	6.76e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.34e-06	6.74e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SULT1E1—coronary artery disease	7.34e-06	6.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GOT1—coronary artery disease	7.27e-06	6.67e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GGT1—coronary artery disease	7.27e-06	6.67e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.26e-06	6.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPX1—coronary artery disease	7.24e-06	6.64e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF1—coronary artery disease	7.08e-06	6.5e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CD36—coronary artery disease	7.05e-06	6.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LPL—coronary artery disease	7.03e-06	6.45e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7e-06	6.42e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HK2—coronary artery disease	7e-06	6.42e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—VCAN—coronary artery disease	7e-06	6.42e-05	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—coronary artery disease	6.97e-06	6.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPP2CA—coronary artery disease	6.96e-06	6.39e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALDOA—coronary artery disease	6.95e-06	6.37e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—DCN—coronary artery disease	6.74e-06	6.19e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	6.71e-06	6.16e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—coronary artery disease	6.68e-06	6.13e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PPP2CA—coronary artery disease	6.6e-06	6.06e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LCAT—coronary artery disease	6.58e-06	6.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.58e-06	6.04e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALDH2—coronary artery disease	6.56e-06	6.02e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTP1—coronary artery disease	6.53e-06	5.99e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PRKCD—coronary artery disease	6.48e-06	5.95e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARGC1A—coronary artery disease	6.47e-06	5.94e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA4—coronary artery disease	6.46e-06	5.93e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—HMOX1—coronary artery disease	6.44e-06	5.91e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.39e-06	5.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LIPC—coronary artery disease	6.39e-06	5.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HBA1—coronary artery disease	6.39e-06	5.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP2C19—coronary artery disease	6.39e-06	5.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	6.39e-06	5.87e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAT—coronary artery disease	6.35e-06	5.83e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOC3—coronary artery disease	6.35e-06	5.83e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AGT—coronary artery disease	6.35e-06	5.82e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—coronary artery disease	6.33e-06	5.81e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LDLR—coronary artery disease	6.31e-06	5.79e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.31e-06	5.79e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.24e-06	5.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCLM—coronary artery disease	6.24e-06	5.73e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC9A1—coronary artery disease	6.24e-06	5.72e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTT1—coronary artery disease	6.24e-06	5.72e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOE—coronary artery disease	6.22e-06	5.71e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOB—coronary artery disease	6.17e-06	5.66e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GCLC—coronary artery disease	6.17e-06	5.66e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CETP—coronary artery disease	6.17e-06	5.66e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—APOA1—coronary artery disease	6.15e-06	5.64e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SDC1—coronary artery disease	6.1e-06	5.6e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.04e-06	5.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.04e-06	5.55e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HIF1A—coronary artery disease	6.04e-06	5.54e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTM1—coronary artery disease	6e-06	5.51e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.95e-06	5.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOE—coronary artery disease	5.9e-06	5.41e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—LPL—coronary artery disease	5.89e-06	5.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.89e-06	5.4e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.87e-06	5.38e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HADH—coronary artery disease	5.87e-06	5.38e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APOA1—coronary artery disease	5.83e-06	5.35e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.76e-06	5.29e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.76e-06	5.29e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.75e-06	5.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPX1—coronary artery disease	5.75e-06	5.27e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CTGF—coronary artery disease	5.63e-06	5.16e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CD36—coronary artery disease	5.6e-06	5.14e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMGCR—coronary artery disease	5.58e-06	5.12e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GOT2—coronary artery disease	5.58e-06	5.12e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX2—coronary artery disease	5.56e-06	5.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.56e-06	5.1e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA2—coronary artery disease	5.56e-06	5.1e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6ST—coronary artery disease	5.54e-06	5.08e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPP2CA—coronary artery disease	5.53e-06	5.07e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.49e-06	5.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX4—coronary artery disease	5.49e-06	5.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HK1—coronary artery disease	5.49e-06	5.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.49e-06	5.04e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—coronary artery disease	5.49e-06	5.04e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HADHA—coronary artery disease	5.43e-06	4.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARG—coronary artery disease	5.42e-06	4.97e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.37e-06	4.92e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POMC—coronary artery disease	5.34e-06	4.9e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KIT—coronary artery disease	5.32e-06	4.88e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPA—coronary artery disease	5.31e-06	4.87e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—coronary artery disease	5.3e-06	4.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.14e-06	4.72e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLCB1—coronary artery disease	5.13e-06	4.71e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GSK3B—coronary artery disease	5.11e-06	4.68e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA5—coronary artery disease	5.09e-06	4.67e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CREB1—coronary artery disease	5.06e-06	4.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AGT—coronary artery disease	5.04e-06	4.62e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.03e-06	4.62e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—P4HB—coronary artery disease	4.99e-06	4.58e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.97e-06	4.56e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6R—coronary artery disease	4.94e-06	4.53e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOE—coronary artery disease	4.94e-06	4.53e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.9e-06	4.49e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—APOA1—coronary artery disease	4.88e-06	4.48e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—coronary artery disease	4.87e-06	4.47e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GGT1—coronary artery disease	4.81e-06	4.42e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GOT1—coronary artery disease	4.81e-06	4.42e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.67e-06	4.29e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NOS3—coronary artery disease	4.66e-06	4.28e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SERPINE1—coronary artery disease	4.63e-06	4.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—VCAN—coronary artery disease	4.62e-06	4.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.58e-06	4.2e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—coronary artery disease	4.48e-06	4.11e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DCN—coronary artery disease	4.45e-06	4.08e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS3—coronary artery disease	4.42e-06	4.05e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.33e-06	3.97e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.32e-06	3.97e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARG—coronary artery disease	4.3e-06	3.95e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAK2—coronary artery disease	4.29e-06	3.94e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.28e-06	3.93e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.26e-06	3.91e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—coronary artery disease	4.26e-06	3.91e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POMC—coronary artery disease	4.24e-06	3.89e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HBA1—coronary artery disease	4.22e-06	3.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LIPC—coronary artery disease	4.22e-06	3.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.22e-06	3.87e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.22e-06	3.87e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAT—coronary artery disease	4.21e-06	3.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOC3—coronary artery disease	4.19e-06	3.84e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LDLR—coronary artery disease	4.16e-06	3.82e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.11e-06	3.78e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.11e-06	3.78e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOB—coronary artery disease	4.08e-06	3.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCLC—coronary artery disease	4.07e-06	3.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CETP—coronary artery disease	4.07e-06	3.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SDC1—coronary artery disease	4.02e-06	3.69e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.97e-06	3.65e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—LPL—coronary artery disease	3.9e-06	3.58e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—coronary artery disease	3.87e-06	3.55e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX1—coronary artery disease	3.81e-06	3.49e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.8e-06	3.49e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.8e-06	3.49e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CTGF—coronary artery disease	3.71e-06	3.41e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CD36—coronary artery disease	3.71e-06	3.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NOS3—coronary artery disease	3.7e-06	3.39e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.68e-06	3.37e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GOT2—coronary artery disease	3.68e-06	3.37e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.66e-06	3.36e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.51e-06	3.22e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.38e-06	3.1e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AGT—coronary artery disease	3.34e-06	3.06e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.28e-06	3.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOE—coronary artery disease	3.27e-06	3e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—APOA1—coronary artery disease	3.23e-06	2.97e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GOT1—coronary artery disease	3.17e-06	2.91e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GGT1—coronary artery disease	3.17e-06	2.91e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.09e-06	2.84e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—coronary artery disease	2.92e-06	2.68e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK1—coronary artery disease	2.86e-06	2.63e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.85e-06	2.62e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARG—coronary artery disease	2.85e-06	2.61e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.83e-06	2.59e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.81e-06	2.58e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POMC—coronary artery disease	2.81e-06	2.58e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAT—coronary artery disease	2.78e-06	2.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOB—coronary artery disease	2.69e-06	2.47e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—coronary artery disease	2.62e-06	2.41e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.62e-06	2.4e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—LPL—coronary artery disease	2.57e-06	2.36e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—coronary artery disease	2.56e-06	2.35e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX1—coronary artery disease	2.51e-06	2.3e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—coronary artery disease	2.49e-06	2.28e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NOS3—coronary artery disease	2.45e-06	2.25e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CD36—coronary artery disease	2.44e-06	2.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.41e-06	2.21e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.32e-06	2.13e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.24e-06	2.06e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AGT—coronary artery disease	2.2e-06	2.02e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—coronary artery disease	2.2e-06	2.02e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOE—coronary artery disease	2.16e-06	1.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—coronary artery disease	2.14e-06	1.97e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—APOA1—coronary artery disease	2.13e-06	1.96e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—coronary artery disease	2.08e-06	1.91e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—coronary artery disease	2.03e-06	1.86e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARG—coronary artery disease	1.88e-06	1.72e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POMC—coronary artery disease	1.85e-06	1.7e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—coronary artery disease	1.7e-06	1.56e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—coronary artery disease	1.69e-06	1.55e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NOS3—coronary artery disease	1.62e-06	1.48e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.48e-06	1.36e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.38e-06	1.26e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—coronary artery disease	1.13e-06	1.03e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.09e-07	8.34e-06	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—coronary artery disease	7.43e-07	6.81e-06	CbGpPWpGaD
